Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €6.85 | €8.75 | 27.737% |
| UCB S.A. | 2 | 0 | 0 | 0 | €124.95 | - | - |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.67 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.06 | €100.00 | 49.120% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.00 | €11.00 | 83.456% |
| Bausch Health Companies Inc. | 3 | 0 | 1 | 0 | €8.15 | €16.47 | 102.263% |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €6.87 | €10.00 | 45.645% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €29.15 | €35.99 | 23.449% |
| Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.70 | 168.304% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.85 | €99.50 | 8.329% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €23.60 | €68.78 | 191.438% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.44 | €8.50 | 32.090% |
| Codexis Inc. | 4 | 2 | 0 | 0 | €2.48 | €8.35 | 236.738% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €23.80 | €26.58 | 11.687% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.75 | €19.86 | 245.477% |
| X4 Pharmaceuticals, Inc. | 4 | 1 | 1 | 1 | €1.09 | €2.76 | 153.003% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.85 | €12.09 | 553.481% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |